Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG.
Capetti AF, Borgonovo F, Mileto D, Gagliardi G, Mariani C, Lupo A, Dedivitiis G, Meraviglia P, Pellicciotta M, Armiento L, Cossu MV, Rizzardini G. Capetti AF, et al. Among authors: mileto d. J Infect. 2021 Aug;83(2):237-279. doi: 10.1016/j.jinf.2021.05.023. Epub 2021 May 27. J Infect. 2021. PMID: 34052240 Free PMC article.
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status.
Antinori S, Cossu MV, Ridolfo AL, Rech R, Bonazzetti C, Pagani G, Gubertini G, Coen M, Magni C, Castelli A, Borghi B, Colombo R, Giorgi R, Angeli E, Mileto D, Milazzo L, Vimercati S, Pellicciotta M, Corbellino M, Torre A, Rusconi S, Oreni L, Gismondo MR, Giacomelli A, Meroni L, Rizzardini G, Galli M. Antinori S, et al. Among authors: mileto d. Pharmacol Res. 2020 Aug;158:104899. doi: 10.1016/j.phrs.2020.104899. Epub 2020 May 11. Pharmacol Res. 2020. PMID: 32407959 Free PMC article. Clinical Trial.
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy.
Morena V, Milazzo L, Oreni L, Bestetti G, Fossali T, Bassoli C, Torre A, Cossu MV, Minari C, Ballone E, Perotti A, Mileto D, Niero F, Merli S, Foschi A, Vimercati S, Rizzardini G, Sollima S, Bradanini L, Galimberti L, Colombo R, Micheli V, Negri C, Ridolfo AL, Meroni L, Galli M, Antinori S, Corbellino M. Morena V, et al. Among authors: mileto d. Eur J Intern Med. 2020 Jun;76:36-42. doi: 10.1016/j.ejim.2020.05.011. Epub 2020 May 21. Eur J Intern Med. 2020. PMID: 32448770 Free PMC article.
Presence and infectivity of SARS-CoV-2 virus in wastewaters and rivers.
Rimoldi SG, Stefani F, Gigantiello A, Polesello S, Comandatore F, Mileto D, Maresca M, Longobardi C, Mancon A, Romeri F, Pagani C, Cappelli F, Roscioli C, Moja L, Gismondo MR, Salerno F. Rimoldi SG, et al. Among authors: mileto d. Sci Total Environ. 2020 Nov 20;744:140911. doi: 10.1016/j.scitotenv.2020.140911. Epub 2020 Jul 14. Sci Total Environ. 2020. PMID: 32693284 Free PMC article.
Analysis of SARS-CoV-2 vertical transmission during pregnancy.
Fenizia C, Biasin M, Cetin I, Vergani P, Mileto D, Spinillo A, Gismondo MR, Perotti F, Callegari C, Mancon A, Cammarata S, Beretta I, Nebuloni M, Trabattoni D, Clerici M, Savasi V. Fenizia C, et al. Among authors: mileto d. Nat Commun. 2020 Oct 12;11(1):5128. doi: 10.1038/s41467-020-18933-4. Nat Commun. 2020. PMID: 33046695 Free PMC article.
Impressive Boosting of Anti-S1/S2 Immunoglobulin G Production in Coronavirus Disease 2019 (COVID-19)-experienced Patients After the First Shot of the BNT162b2 Messenger RNA COVID-19 Vaccine.
Capetti AF, Stangalini CA, Borgonovo F, Mileto D, Oreni L, Dedivitiis G, Lupo A, Cossu MV, Bilardo L, Giacomelli A, Galli M, Rizzardini G. Capetti AF, et al. Among authors: mileto d. Clin Infect Dis. 2021 Sep 15;73(6):e1402-e1403. doi: 10.1093/cid/ciab214. Clin Infect Dis. 2021. PMID: 33693610 Free PMC article. No abstract available.
Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: A cross-sectional study: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine.
Pezzati L, Giacomelli A, Mileto D, Conti F, Gagliardi G, Rizzo A, Milazzo L, Schiuma M, Covizzi A, Siano M, Bassoli C, Passerini M, Piscaglia M, Torre A, Oreni L, Rizzardini G, Galli M, Ridolfo AL, Antinori S. Pezzati L, et al. Among authors: mileto d. J Infect. 2021 Sep;83(3):381-412. doi: 10.1016/j.jinf.2021.05.029. Epub 2021 May 29. J Infect. 2021. PMID: 34062183 Free PMC article. No abstract available.
SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response.
Mileto D, Fenizia C, Cutrera M, Gagliardi G, Gigantiello A, De Silvestri A, Rizzo A, Mancon A, Bianchi M, De Poli F, Cuomo M, Burgo I, Longo M, Rimoldi SG, Pagani C, Grosso S, Micheli V, Rizzardini G, Grande R, Biasin M, Gismondo MR, Lombardi A. Mileto D, et al. Emerg Microbes Infect. 2021 Dec;10(1):2235-2243. doi: 10.1080/22221751.2021.2004866. Emerg Microbes Infect. 2021. PMID: 34749573 Free PMC article.
62 results